By Devika Patel
Knoxville, Tenn., July 24 - Antares Pharma, Inc. plans to raise $8.5 million in a registered direct offering of units, according to a prospectus supplement filed Friday with the Securities and Exchange Commission.
The company will sell 10,625,000 units at $0.80 apiece. Each unit consists of one common share and a five-year warrant to purchase 0.4 shares at $1.00 apiece.
Cowen and Co., LLC, Oppenheimer & Co., Inc. and Ladenburg Thalmann & Co. Inc. are the agents.
Settlement is expected on July 29.
Proceeds will be used for general corporate purposes.
Located in Ewing, N.J., Antares develops drug delivery systems, including a transdermal patch.
| Issuer: | Antares Pharma, Inc.
|
| Issue: | Units of one common share and one warrant for 0.4 shares
|
| Amount: | $8.5 million
|
| Units: | 10,625,000
|
| Price: | $0.80
|
| Warrants: | One warrant for 0.4 shares per unit
|
| Warrant expiration: | Five years
|
| Warrant strike price: | $1.00
|
| Agent: | Cowen and Co., LLC, Oppenheimer & Co., Inc. and Ladenburg Thalmann & Co. Inc.
|
| Pricing date: | July 24
|
| Settlement date: | July 29
|
| Stock symbol: | Amex: AIS
|
| Stock price: | $0.90 at close July 23
|
| Market capitalization: | $57.3 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
